Cookie comes from a multidisciplinary scientific background and is actively involved in evaluating investment opportunities for Pappas Capital. Prior to joining Pappas in 2019, she worked as an analyst at M. Ventures, a subsidiary of Merck KGaA, in Darmstadt, Germany. During her time at M. Ventures, Cookie performed market analysis in a wide range of life science and therapeutic areas for venture opportunities, in alignment with global corporate strategies. She also served on the financial team and received training in venture fund controlling.
Before becoming a venture capitalist, Cookie was a researcher at Stony Brook University, where she developed platform technologies in cardiac optogenetics and single cell analysis. In 2016, Cookie was selected as a recipient of the Program for Excellence in Science Award from AAAS. During her time at Stony Brook, Cookie also worked with the New York State Center for Biotechnology on assessing the commercial potential of discovery-stage programs and formulating their development and financing strategies. She supplemented her life science technical expertise with financial understanding by passing the CFA Level I exam. When she is not scouting new technologies, Cookie enjoys foraging wild mushrooms in the forests, traveling, and Latin dancing.
Cookie currently serves as a director for Allievex and as an observer for CuraSen.
Stony Brook University (PhD in Biomedical Engineering)
© 2022 Pappas Capital, LLC. ALL RIGHTS RESERVED.